
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $534.8M | -- | -- | $0.43 | -- |
08/04/2025 | Q2 | $422.3M | -- | -- | $0.07 | -- |
05/05/2025 | Q1 | $310.9M | $352.8M | -$0.10 | -$0.25 | $0.15 |
02/27/2025 | Q4 | $525.1M | $532.7M | $0.70 | $0.80 | -$0.10 |
11/07/2024 | Q3 | $486.5M | $500.9M | $0.33 | $0.53 | -$0.20 |
08/05/2024 | Q2 | $376.1M | $438M | $0.09 | $0.26 | -$0.17 |
05/07/2024 | Q1 | $263.3M | $298.4M | -$0.06 | -$0.06 | $0.00 |
02/28/2024 | Q4 | $400M | $441.4M | $0.63 | $0.59 | $0.04 |
11/06/2023 | Q3 | -- | -- | $0.40 | $0.46 | -$0.06 |
07/31/2023 | Q2 | -- | -- | $0.12 | $0.18 | -$0.06 |
05/01/2023 | Q1 | -- | -- | $0.02 | $0.04 | -$0.02 |
02/27/2023 | Q4 | -- | -- | $0.34 | $0.38 | -$0.04 |
11/01/2022 | Q3 | -- | -- | $0.51 | $0.70 | -$0.19 |
08/01/2022 | Q2 | -- | -- | $0.61 | $0.45 | $0.16 |
05/02/2022 | Q1 | -- | -- | $0.32 | $0.28 | $0.04 |
02/28/2022 | Q4 | -- | -- | $0.53 | $0.43 | $0.10 |
11/01/2021 | Q3 | -- | -- | $0.33 | $0.33 | -$0.00 |
08/02/2021 | Q2 | -- | -- | $0.26 | $0.26 | $0.00 |
05/04/2021 | Q1 | -- | -- | $0.22 | $0.10 | $0.12 |
03/01/2021 | Q4 | -- | -- | $0.47 | $0.29 | $0.18 |
11/02/2020 | Q3 | -- | -- | $0.41 | $0.25 | $0.16 |
08/03/2020 | Q2 | -- | -- | $0.09 | $0.07 | $0.03 |
05/04/2020 | Q1 | -- | -- | $0.13 | $0.08 | $0.05 |
03/02/2020 | Q4 | -- | -- | $0.46 | $0.39 | $0.07 |
11/05/2019 | Q3 | -- | -- | $0.19 | $0.26 | -$0.07 |
08/08/2019 | Q2 | -- | -- | $0.18 | $0.15 | $0.03 |
04/30/2019 | Q1 | -- | -- | $0.02 | -$0.02 | $0.04 |
03/06/2019 | Q4 | -- | -- | $0.23 | $0.18 | $0.05 |
10/30/2018 | Q3 | -- | -- | $0.23 | $0.15 | $0.08 |
08/07/2018 | Q2 | -- | -- | $0.18 | $0.11 | $0.08 |
05/01/2018 | Q1 | -- | -- | $0.16 | $0.05 | $0.11 |
03/06/2018 | Q4 | -- | -- | $0.48 | $0.14 | $0.34 |
10/31/2017 | Q3 | -- | -- | $0.18 | $0.15 | $0.03 |
07/18/2017 | Q2 | -- | -- | $0.13 | $0.07 | $0.06 |
05/02/2017 | Q1 | -- | -- | -$0.01 | $0.03 | -$0.04 |
03/02/2017 | Q4 | -- | -- | $0.08 | $0.03 | $0.05 |
11/01/2016 | Q3 | -- | -- | $0.16 | $0.07 | $0.09 |
08/09/2016 | Q2 | -- | -- | $0.08 | $0.04 | $0.04 |
05/05/2016 | Q1 | -- | -- | $0.03 | -- | -- |
03/03/2016 | Q4 | -- | -- | $0.09 | $0.10 | -$0.01 |
11/05/2015 | Q3 | -- | -- | $0.09 | $0.12 | -$0.03 |
Ameresco reported $352.8M worth of top line sales in its most recent quarter.
Ameresco announced earnings per share of -$0.10 which represents a beat of analyst forecast a -$0.25 per share.
Ameresco reported $51.9M that represents $0.99 per share over the last quarter.
Ameresco's earnings are forecast to decrease from $1.07 per share to $1.18 per share next year representing a decrease of -18.1%.
Ameresco's next earnings date is August 4, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.